Back to Journals » OncoTargets and Therapy » Volume 14

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

Authors Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

Received 29 March 2021

Accepted for publication 29 March 2021

Published 6 April 2021 Volume 2021:14 Pages 2337—2338


Wang Q, Liao J, He Z, et al. Onco Targets Ther. 2020;13:10983–10994

The Corrigendum notice ( that was published January 12, 2021 was incorrect. The authors have advised on page 10993, Funding section, “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos. 2017J01261 and 2016JD1488)” should have been “This study was supported by grants from the Startup Fund for Scientific Research, Fujian Medical University (grant no. 2017XQ1217), Joint Funds for the Innovation of Science and Technology, Fujian Province (grant no. 2017Y9080), and Fujian Provincial Sci & Tech Guiding Project (grant no. 2018Y0017).”

The authors apologize for this error.

Read the original article
Previous corrigendum has been published

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]